CCI Imposes ₹40 Lakh Penalty On Goldman Sachs For Failure To Notify Investment In Biocon Biologics U/S 6(2) Of Competition Act

The CCI imposed a penalty of INR 40 lakh on Goldman Sachs for failing to notify its investment in Biocon Biologics US under the Competition Act. The penalty was levied after the company violated merger and acquisition notification requirements under the Act, which mandates companies to inform the CCI of certain deals that could affect competition. The decision serves as a reminder to companies of the importance of timely compliance with competition law regulations.